Steele Foundation for Hope is a self-funded 501(c)(3) private foundation that provides patient, philanthropic investment capital to for-profit companies and social enterprises developing products and services addressing global humanitarian challenges in healthcare, water, food, and education.
40% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (40% of deals). Average disclosed round size is $16.1M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Epicore Biosystems | Series B | $32M | May 2025 |
| Epicore Biosystems | Series B | $26M | Feb 2025 |
 Sibel Health | Series C | — | Jan 2025 |
| WWater Access Rwanda | Seed | $1M | — |
| AAI Diagnostics | Unknown | $5.2M | — |
Top Co-Investors
Last updated: 8 September 2026